EP Patent

EP1452524A1 — "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses"

Assigned to UCB Pharma SA Belgium · Expires 2004-09-01 · 22y expired

What this patent protects

A compound selected from the (4R) and (4S) diastereoisomers of (2S)-2-[2-oxo-4-propylpyrrolidinyl]butanamide or a pharmaceutically acceptable salt thereof. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.

USPTO Abstract

A compound selected from the (4R) and (4S) diastereoisomers of (2S)-2-[2-oxo-4-propylpyrrolidinyl]butanamide or a pharmaceutically acceptable salt thereof. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.

Drugs covered by this patent

Patent Metadata

Patent number
EP1452524A1
Jurisdiction
EP
Classification
—
Expires
2004-09-01
Drug substance claim
No
Drug product claim
No
Assignee
UCB Pharma SA Belgium
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.